Repaglinide 0.5 mg + Voglibose 0.3 mg Tablet (Reparon-V 0.5/0.3)
Repaglinide 0.5 mg + Voglibose 0.3 mg
| Composition | Repaglinide 0.5 mg + Voglibose 0.3 mg |
|---|---|
| Dosage Form | Tablet |
| Pack Type | Box |
| Pack Size | 10 x 10 (Alu-Alu) |
| MRP | ₹ 1690 |
| Therapy | Cardiac + Diabetic — Meglitinide + biguanide / alpha-glucosidase inhibitor |
| Storage | Store below 25°C. |
WhatsApp EnquiryCall: +919041677932
For chemists, distributors and doctors: Reparon-V 0.5/0.3 (repaglinide 0.5 mg + voglibose 0.3 mg tablet) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.
About Reparon-V 0.5/0.3 Tablet
Reparon-V 0.5/0.3 Tablet contains Repaglinide 0.5 mg + Voglibose 0.3 mg. Repaglinide produces a short, rapid insulin spike at mealtimes, providing flexible post-prandial glucose control.
Indicated for type-2 diabetes — particularly in patients with prominent post-prandial hyperglycaemia, irregular meal patterns or older patients prone to hypoglycaemia with long-acting sulphonylureas.
Camrut Healthcare manufactures the Reparon range under WHO-GMP conditions for PCD pharma franchise across India.
Reparon-V 0.5/0.3 का उपयोग (हिंदी में): खाने के बाद शुगर नियंत्रण की दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।
Indications
- Type-2 diabetes with post-prandial hyperglycaemia
- Patients with irregular meal patterns
- Elderly type-2 diabetics needing flexible glucose control
Mechanism of Action
Repaglinide is a meglitinide insulin secretagogue. It closes pancreatic beta-cell ATP-sensitive K+ channels (binding a different site than sulphonylureas), depolarising the cell and triggering insulin secretion. Short half-life produces a rapid, post-prandial insulin spike — useful for control of postprandial hyperglycaemia. Voglibose is an alpha-glucosidase inhibitor that delays intestinal carbohydrate absorption — synergistic for post-prandial control.
Dosage & Administration
['Adults: take 15–30 minutes before each main meal', 'Skip dose if skipping meal', 'Titrate based on glycaemic response', 'Use under physician supervision']
Side Effects
['Hypoglycaemia (less than long-acting sulphonylureas)', 'Weight gain (mild)', 'GI upset']
Contraindications & Precautions
['Type-1 diabetes', 'Diabetic ketoacidosis', 'Severe hepatic impairment', 'Pregnancy and breastfeeding']
Storage
Store below 25°C.
Part of our PCD pharma franchise range, available on a monopoly basis – see the cardiac diabetic PCD franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Reparon-V 0.5/0.3 Tablet is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
q
a
q
a
q
a
q
a
q
a
Related Products